XML 42 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Cash flows from operating activities:    
Net income (loss) $ 180,094 $ (6,565)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Loss on early extinguishment of debt   133
Gain on remeasurement, sale or write down of assets, net (40,603) (4,128)
(Gain) loss on the disposition of assets, net from discontinued operations (74,906) 37,648
Depreciation and amortization 234,410 208,832
Amortization of net discount on mortgages, bank and other notes payable 661 6,993
Amortization of share and unit-based plans 8,950 9,428
Provision for doubtful accounts 2,200 2,375
Income tax benefit (2,159) (5,811)
Equity in income of unconsolidated joint ventures (68,624) (75,521)
Co-venture expense 4,462 3,779
Distributions of income from unconsolidated joint ventures 14,682 10,973
Changes in assets and liabilities, net of acquisitions and dispositions:    
Tenant and other receivables (1,336) (1,360)
Other assets 23,114 (2,658)
Due from affiliates (4,208) 2,239
Accounts payable and accrued expenses 16,272 13,307
Other accrued liabilities (36,830) (19,179)
Net cash provided by operating activities 256,179 180,485
Cash flows from investing activities:    
Acquisitions of property (70,925) (108,954)
Development, redevelopment, expansion and renovation of Centers (84,283) (63,285)
Property improvements (24,846) (34,932)
Issuance of notes receivable (12,500)  
Proceeds from maturities of marketable securities 788 772
Deferred leasing costs (20,875) (26,635)
Distributions from unconsolidated joint ventures 217,393 193,849
Contributions to unconsolidated joint ventures (47,513) (149,841)
Collection of/loans to unconsolidated joint ventures, net 661 (866)
Proceeds from sale of assets 130,691 6,255
Restricted cash 2,886 (879)
Net cash provided by (used in) investing activities 91,477 (184,516)
Cash flows from financing activities:    
Proceeds from mortgages, bank and other notes payable 1,580,885 432,000
Payments on mortgages, bank and other notes payable (1,813,271) (450,775)
Deferred financing costs (4,639) (17,604)
Proceeds from sale, net 175,869  
Proceeds from share and unit-based plans 656 369
Exercise of stock warrants (3,448)  
Redemption of noncontrolling interests (71) (11,398)
Contribution from noncontrolling interests 918  
Dividends and distributions (240,635) (217,599)
Distributions to co-venture partner (34,615) (37,187)
Net cash used in financing activities (338,351) (302,194)
Net increase (decrease) in cash and cash equivalents 9,305 (306,225)
Cash and cash equivalents, beginning of period 67,248 445,645
Cash and cash equivalents, end of period 76,553 139,420
Supplemental cash flow information:    
Cash payments for interest, net of amounts capitalized 146,381 128,105
Non-cash transactions:    
Accrued development costs included in accounts payable and accrued expenses and other accrued liabilities 30,591 14,828
Acquisition of properties by assumption of mortgage note payable and other accrued liabilities   192,566
Disposition of property in exchange for investments in unconsolidated joint ventures   56,952
Mortgage notes payable settled by deed-in-lieu of foreclosure 185,000  
Conversion of noncontrolling interests to common shares $ 11,978 $ 20,992